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Abstract A 25 kDa C-terminal tryptic fragment of elongation 
factor "Is has been purified to homogeneity. Experimental evi- 
dence suggests that the 25 kDa C-terminal and the 5.3 kDa 
N-terminal fragments are structurally independent domains. The 
N-terminal fragment is shown to be essential for the nucleotide 
exchange activity. Crystals of the C-terminal fragment belong to 
space group P2 or P21. The diffraction pattern shows a pro- 
nounced pseudo-C2 symmetry at low resolution. This pseudo sym- 
metry increases when the crystals are irradiated with X-rays for 
a few hours. 
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I. Introduction 
The reaction cycle of elongation factor Tu (EF-Tu) is an 
integral part of protein biosynthesis in procaryotic organisms 
(for a review see [1]). EF-Tu forms a ternary complex with 
guanosine-triphosphate (GTP) and aminoacyl-tRNA (aa- 
tRNA). This complex delivers the activated amino acid to the 
A-site of the ribosome [2-3]. After GTP-hydrolysis EF-Tu 
leaves the ribosome as a binary complex with guanosine-di- 
phosphate (GDP) [3-5]. In Escherichia coil (E. eoli) the biosyn- 
thesis of peptide bonds is kept at a rate of approx. 10-20 
bonds/s/ribosome [67]. In order to maintain the rate of forma- 
tion of peptide bonds, the conversion of EF-Tu:GDP to EF- 
Tu:GTP:aa-tRNA must proceed with at least the same rate. 
Different groups [8-11] have determined values of the rate 
constant for dissociation of GDP from EF-Tu in the range 10 -2 
to 10 -3 s -1. These values are much too low to account for the 
in vivo rate of formation of peptide bonds. In the presence of 
the 30.3 kDa cytoplasmic protein elongation factor Ts (EF-Ts) 
an EF-Tu:EF-Ts:GDP intermediate is rapidly produced. The 
nucleotide GDP dissociates from this intermediate with a rate 
constant of 10 ~ to 103 s ~ [10-11] resulting in the stable EF- 
Tu: EF-Ts complex. Binding of GTP to EF-Tu: EF-Ts is very 
fast, while the dissociation of EF-Ts from EF- 
Tu:EF-Ts:GTP proceeds with a rate constant of 13 s -1 [12]. 
The exchange reaction is summarized in Fig. 1. The overall 
increase of the nucleotide xchange rate in the presence of 
EF-Ts is of the order 103 to 10 4, in agreement with the rate of 
peptide bond formation (for a review on the rate-constants in 
the exchange reaction see [12]). 
Hwang and Miller [13] have shown that the exchange reac- 
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tion follows the substituted enzyme pathway as illustrated in 
Fig. 1 and several reports uggest the presence of a structural 
isomerization-step in the EF-Tu: EF-Ts: GDP complex [14-17]. 
It has been demonstrated [18] that the site of interaction with 
EF-Ts is partly located in domain II/III of EF-Tu which is in 
good agreement with the previously proposed EF-Ts binding 
site in domain III [19-20]. However, a recent study by Hwang 
et al. [21] indicates that also residues 154-199 located in domain 
I of EF-Tu are involved in EF-Ts binding. Very little structural 
information about EF-Ts is available, other than the nucleotide 
sequence of the EF-Ts encoding ene tsf[22]. More information 
concerning the EF-Tu:EF-Ts interaction could come from X- 
ray analysis of EF-Ts and the EF-Tu: EF-Ts complex. Though 
crystals of this complex have been obtained [23-24] no structure 
has been reported. 
In this work we report a possible two-domain-structure of 
EF-Ts and the successful crystallization and preliminary X-ray 
investigation of a 25 kDa C-terminal fragment obtained by 
tryptic digestion of cloned and overexpressed intact EF-Ts 
from E. coll. 
2. Materials and methods 
2.1. Materials 
E. coli JM 105 [25] and N4830-1, which is a P I transductant of N4830 
[26], were used for cloning and expression. Restriction endonucleases 
and modifying enzymes were purchased from Boehringer-Mannheim, 
Germany. Vent polymerase for PCR was from New England Biolab, 
USA. Sequenase v rsion 2.0 was from USB, USA, and [a-35S]dATP 
(> 1000 Ci/mmol) was from Amersham International, UK. Q- and 
S-Sepharoses were from Pharmacia, Sweden, and AcA54 from IBF, 
France. DEAE-Separon was from TESSEK, Denmark and Centricon 
concentrators were from AMICON, USA. The pGEX-I vector [27] was 
kindly provided by Naomi Halachmi, Technicon, Haifa. T4 ligase and 
factor X~ were gifts of H.C. Thogersen, Laboratory of Gene Expres- 
sion, Aarhus University. L-1-Tosylamide-2-phenylethyl chloromethyl 
ketone (TPCK) treated trypsin, elastase, chymotrypsin, soybean trypsin 
inhibitor, phenylmethylsulfonyl fluoride (PMSF), DL-dithiothreitol 
(DTT) and Ficoll were from Sigma, USA, OGP was from Boehringer- 
Mannheim, Germany and [3H]GDP (14 Ci/mmol) used in activity as- 
says was from Amersham International, UK. Filters with pore size 0.45 
/lm were from Gelman Sciences, USA. Chemicals not described above 
were of analytical grade. 
2.2. Cloning in expression vectors 
Prior to cloning, the tsfgene, which encodes E. coli EF-Ts, was PCR 
amplified according to the manufactors instruction (New England Bio- 
labs). For cloning in the inducible runaway expression vector pCP40 
[28] the following two primers were used: 5'-AGGACGAATTCCAA- 
GGAATATAGCCATGGCTGAAATTACCGC and 5'-AGGACGA- 
AGCTTTTAAGACTGCTTGGACAT. Embedded restriction sites 
made possible a directional cloning in the EcoRI/HindIII sites of 
pCP40. For cloning in the pGEX system the following primers were 
used: 5'-AGGACGGATCCCGGTTCCATCGAGGGTCGTGCTG- 
AAATTACCGCA and 5'-AGGACGGATCCTCATTAAGACTGC- 
TTGGACATC. EF-Ts is in this system expressed aspart of a fusion 
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Fig. 1. Overview of the EF-Ts cycle in £ eoli. 
protein, however, the primer and cloning design makes possible a re- 
lease of authentic EF-Ts subsequent tocleavage with the blood clotting 
factor X~. Upon cloning the t~f gene sequences were confirmed by 
sequencing using Sangers dideoxy chain-termination method [29]. 
2.3. Expression and purification of EF-Ts 
Upon propagation i the strain N4830-1, which is a 2 lysogen for the 
temperature sensitive repressor ci857, expression was induced at 
A450 = 0.8 by increasing the temperature to42°C for a few hours. The 
non-ribosomal fraction of crude E. coli cell extract was chromatogra- 
phed on Q-Sepharose using a linear 1(L250 mM KCI gradient in 50 mM 
Tris-HC1, pH 7.6, 1 mM DTT, 0.5 mM PMSF, 15 pM GDP. Active 
fractions were desalted and acidified to pH 5 and further chromato- 
graphed on S-Sepharose using a linear 10-500 mM NaCI gradient in 
50 mM sodium acetate, pH 5.0, 1 mM DTT, 0.5 mM PMSF, 15 pM 
GDP. Finally EF-Ts was purified by gel filtration on Ultrogel AcA54 
in a buffer containing 50 mM Tris-HCl, pH 7.6, 80 mM KC1, 1 mM 
DTT, 0.5 mM PMSF and 15/tM GDP. 
Expression, purification and release of authentic EF-Ts, using the 
pGEX gene fusion system, was done as described previously for recom- 
binant EF-Tu [30]. 
Protein obtained from either of the two expression systems was 
further purified by anion exchange HPLC on DEAE-Separon using a 
0-500 mM KC1 gradient in 20 mM Tris-HCl, pH 7.5, 10 mM MgC12, 
1 mM DTT, 0.5 mM PMSF. Buffer-exchange to storage buffer (20 mM 
Tris-HC1, pH 7.0, 10 mM MgCl2, 1 mM DTT, 0.5 mM PMSF) and 
concentration was done with Centricon-C10 concentrators. Protein 
concentration was measured using the modified method of Bradford 
[31]. The protein was frozen in liquid nitrogen and stored at -80°C. 
2.4. Electrospray mass spectrometry 
The electrospray mass spectra of the intact protein were recorded on 
a Vestec electrospray mass spectrometer (Vestec Corp., Houston, TX). 
The samples were dissolved in 2% acetic acid/50% methanol to a con- 
centration of approximately 0.2/@/pl and introduced by a syringe 
pump at a flow rate of 1/A/min. The spectra were recorded with a scan 
rate of 10 s/scan using a mass window of m/z 500-1500 [32]. The 
molecular weight of the protein was calculated by wieghted averaging 
as described [33]. 
2.5. Purification of the C-terminal fragment 
Purified EF-Ts at a concentration f 3.4 mg/ml in a buffer containing 
6.7 mM Tris-HC1, pH 7.0, 3.3 mM MgC12, 25% (v/v) glycerol was 
digested with TPCK treated trypsin for 17 h at 4°C. The weight ratio 
of trypsin to EF-Ts was 1 : 1000 and the reaction was stopped by adding 
PMSF to a concentration f 0.5 mM. The digest was subjected to anion 
exchange HPLC using a 0-500 mM KCI gradient in 30 mM Tris-HC1, 
pH 8.5, 10 mM MgC12, 1 mM DTT, 0.5 mM PMSF). Prior to freezing 
in storage buffer soybean trypsin inhibitor was added in a weight ratio 
of 3 : 1 relative to the originally added amount of trypsin. 
2.6. Analysis of the C-terminal fragment 
N-Terminal sequencing was performed on an Applied Biosystems 
477A Protein Sequencer (Applied Biosystems, USA) using the standard 
Edman degradation method. Analysis of amino acid composition was 
done as described by Sottrup-Jensen [34]. Nucleotide xchange activity 
measurements on both intact EF-Ts and the C-terminal fragment were 
performed as described by Miller and Weissbach [35]. 
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Fig. 2. Trypsin treatment of intact EF-Ts analysed with SDS-PAGE. 
SDS-PAGE was performed as described in [44]. Lane 14  = intact 
EF-Ts was incubated with 1% (w/w) trypsin under the conditions de- 
scribed in section 2 but glycerol was omitted. Samples of 0.7 pg were 
withdrawn after 5, 15, 30 and 60 min. Lane 5 = molecular weight 
markers (Pharmacia, Sweden). Lane (~9 = same as lane 14  but with 
25% (v/v) glycerol in the incubation mixture. Lane 10 = 0.7 pg intact 
EF-Ts. Lane 11 -- 0.7 pg C-terminal fragment. Lane 12 = washed and 
redissolved crystal. The panel on the right shows the position and M r 
(kDa) of the molecular weight markers. The panel on the left shows 
positions of intact EF-Ts and the major tryptic fragment with an appar- 
ent molecular weight of 27 kDa (27k). 
sion in 24-well Cryschem-trays (Charles Supper Co., USA). Sitting 
drops of 4~10 ,ul composed of equal amounts of protein in storage 
buffer and reservoir were equilibrated against a reservoir of 800/11. All 
reservoirs contained I mM DTT and 0.5 mM PMSF. Since the reservoir 
controls the pH when using ammonium sulphate [36] all reservoirs 
contained 10 mM MES or HEPES and were adjusted to the desired pH 
with Tris. All crystallizations were set up using a modified Gilson 
crystallization robot [37]. All solutions used for crystallization were 
filtered through 0.45 pm pore size filters prior to use. Crystal density 
measurements were done using the Ficoll gradient method [38]. Crystals 
were crosslinked by adding 1% (w/v) glutardialdehyde to the reservoir 
and leaving overnight prior to density measurements. X-Ray diffrac- 
tion studies were performed on a FR571 rotating anode (Enraf-Nonius, 
Holland) operated at 45 kV, 85 mA and equipped with a FAST area 
detector (Enraf-Nonius, Delft) or an oscillation camera. Data process- 
ing was done using the MADNES software package [39] and the pro- 
gram PROCOR [40]. 
3. Results 
Plasmid encoded EF-Ts was analyzed by mass spectrometry. 
The mass of pCP4Otsf encoded EF-Ts was determined to be 
30294 + 6 Da and when expressed as a fusion protein in the 
pGEX system the mass of released EF-Ts was 30296 + 6. As 
the theoretical mass of EF-Ts without the N-terminal methion- 
ine is 30292 the results strongly indicate that the N-terminal 
Table 1 
N-Terminal sequencing of the C-terminal fragment 
Cycle # Amino acid Amount 
1 Ala/Lys 112/95 
2 Gly/Ala 126/195 
3 Asn/Gly 84/208 
4 Val/Asn 112/181 
2. Z Crystallization and X-ray analysis of the C-terminal fragment The amino acids and the corresponding amounts in pmol were deter- 
Crystallization of the C-terminal fragment was done by vapour diffu- mined for the first 4 cycles in the automated Edman degradation. 
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Fig. 3. Amino acid sequence of EF-Ts as derived from the gene se- 
quence [22]. Trypsin cleavage occurs on the C-terminal side of the 
residues marked with asterisks. 
methionine of authentic EF-Ts is lacking and that posttransla- 
tional modifications are not present. A minor peak in the spec- 
trum of pCP4Otsfencoded EF-Ts indicated that a 5-10% frac- 
tion of overexpressed EF-Ts possibly possess an N-terminal 
formylated methionine, i.e. the mass being 150 Da higher. The 
yield of purified EF-Ts expressed from pCP40 was in the range 
of 1 mg/g wet cell paste and the yield of purified EF-Ts fusion 
protein about 10 mg/g wet cell paste. The following results were 
obtained using EF-Ts purified from the pGEX system. 
Trypsin treatment performed as described in section 2 gave 
a major fragment with a molecular weight of 27 kDa as esti- 
mated from SDS-PAGE (Fig. 2). When glycerol was omitted 
two additional fragments of 19 and 18 kDa were produced (Fig. 
2). Digestion of intact EF-Ts with elastase, and to a lesser 
extent chymotrypsin, revealed the presence of a fragment of 
approximately the same size as the major tryptic fragment (not 
shown). In anion exchange HPLC the major fragment always 
eluted in two very poorly resolved peaks. When present the two 
additional fragments of 19 and 18 kDa coeluted with the major 
fragment. Remaining intact EF-Ts was separating well from the 
major fragment (purification results are not shown). The purity 
of the major fragment after purification is shown in Fig. 2. 
N-Terminal sequencing of the major fragment revealed a 
double sequence in which the two sequences were occurring in 
approximately the same amounts (Table 1). This pattern could 
be fitted perfectly into the sequence of EF-Ts revealing two 
adjacent cleavage sites at the carboxy-side of lysine-51 and 
lysine-52 (Fig. 3). The true molecular weight of the major frag- 
ment (in the following refered to as the C-terminal fragment) 
was calculated from the sequence to be 25 kDa. Analysis of the 
amino acid composition of the C-terminal fragment as well as 
of intact EF-Ts was performed. Different molar ratios of amino 
acids were predicted from the sequence for both intact EF-Ts 
and the C-terminal fragment and the same ratios were calcu- 
lated from the experimental data. For both the C-terminal 
fragment and intact EF-Ts the experimental values were found 
to be consistent with the values predicted from the sequence. 
The most prominent of these ratios are shown in Table 2. We 
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Fig. 4. Nucleotide xchange measurements on intact EF-Ts and the 
C-terminal fragment. Exchange activity is plotted against the amount 
of added EF-Ts (abscissa in top of figure) or C-terminal fragment 
(abscissa in bottom of figure). 
therefore conclude that the two tryptic fragments dissociate 
after the hydrolysis. 
Nucleotide xchange activity measurements on intact EF-Ts 
showed a specific activity of intact EF-Ts of 19.7 U/pmol. The 
specific activity of the C-terminal fragment was estimated to be 
0.03 U/pmol (Fig. 4). One U is defined as described in [35]. 
For preliminary crystallization trials partly trypsinized EF- 
Ts was used. This was obtained by adding 1% (w/w) trypsin to 
10 mg/ml intact EF-Ts in storage buffer. After incubation for 
15 min on ice the reaction was stopped by adding 3% (w/w) 
soybean trypsin inhibitor. Spontaneous nucleation and growth 
of many very small crystals occurred under the conditions 
shown in Table 3. For unknown reasons nucleation of this 
crystal form did not take place with purified material using the 
same conditions. Instead massive nucleation of very thin nee- 
dles occurred. However, streakseeding [41] using the crystals 
from partly trypsinized EF-Ts produced small single crystals 
from the purified C-terminal fragment. The best of these with 
a size of approx. 0.05 mm were used in macroseeding [41] with 
purified material to obtain crystals suitable for X-ray studies 
Table 2 
Analysis of the amino acid composition ofthe C-terminal fragment and 
intact EF-Ts 
Amino Theoretical Observed Theoretical Observed 
acid ratio ratio ratio ratio 
ratio intact intact C-terminal C-terminal 
EF-Ts EF-Ts fragment fragment 
Val/Ala 0.744 0.736 0.933 0.905 
Pro/Leu 0.313 0.301 0.417 0.407 
Met/Phe 0.900 0.880 0.600 0.592 
Fig. 5. Crystal of the C-terminal fragment obtained by macroseeding. 
The dimensions of the crystal is 0.2 x 0.2 × 0.12 mm ~ 
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Fig. 6.2 ° oscillation photographs showing C2 symmetry increasing with time. (A) The crystal was exposed for 5 h at a crystal to film distance of 
86 mm. The photograph shows the slightly misoriented a*, b* plane with the two axes oriented as shown. The resolution on the edge of the circular 
area is 2.6 A. (B) Oscillation photograph obtained from the same crystal using the same conditions and covering the same oscillation range but in 
direct continuation of (A). 
(Fig. 5). SDS-PAGE of washed and redissolved crystals gave 
a single band of the same molecular weight as the C-terminal 
fragment (Fig. 2). Crystallization was found to be absolutely 
dependent on the presence of the non-ionic detergent n-octyl- 
fl-o-glycopyranoside (OGP). Glycerol helped to reduce the nu- 
cleation of the thin needles described above. It also increased 
the rate of crystal growth by a factor of 3. Crystallization 
conditions are listed in Table 3. 
Crystals diffracted X-rays to a maximum resolution of 3.0 A 
on an oscillation camera (Fig. 6). Several partial datasets were 
collected from which the cell dimensions were determined to be 
a = 111.0 ,~, b = 96.0 ~, c = 84.3 ~, f l  = 100.2 ° on average with 
less than 1% deviation between different crystals. The 
spacegroup was found to be P2 or P21 but exhibiting pseudo 
C2 symmetry as illustrated by the intensity statistics of one of 
the partial datasets (Table 4). Similar statistics were found for 
all the other partial datasets as well. During X-ray exposure the 
pseudo C2 symmetry of the diffraction pattern increased to an 
extent hat a complete transformation to spacegroup C2 can be 
assumed (Fig. 6). The cell parameters remained constant during 
this transformation. The possibility of spacegroup P2j could 
not be eliminated because of the pseudo C2 symmetry giving 
absences overlapping with absences in spacegroup P2j. The 
datasets collected had more than 50% reflections with 
I /s ig l  > 3 at a resolution of 3.6 ]~. Rsy m was  generally very high 
for data with a resolution better than 6 /~ in all the datasets 
(Table 4). However these R-factors could be diminished consid- 
erably by integrating the same data in spacegroup C2 instead 
of P2 (Table IV). The crystals were stable in the beam for at 
least 5 h showing beginning decay of the high resolution reflec- 
tions after this period of exposure. 
Crystals were not stable in the Ficoll gradient used for den- 
sity measurements if crosslinking with glutardialdehyde .was 
omitted. Crosslinking did not affect the morphology of the 
crystals. A density of 1.190 was determined giving a protein 
content in the crystals of 54.1%. A number of 8 monomers per 
Table 3 
Crystallization conditions for the C-terminal fragment 
Spontaneous nucleation" Streakseeding Macroseeding 
Precipitant: 52 54% (NH4)2SO4 b 48-49% (NH4)2SO 4 48-49% (NH4)2SO 4
pH: 7.2 8.0 6.3-7.0 6.3 7.0 
Buffer: Tris/HEPES Tris/HEPES or Tris/MES Tris/HEPES or Tris/MES 
Additives: 2% (w/v) PEG6000 0.5% (w/v) OGP 0.5% (w/v) OGP 
0.5% (w/v) OGP 5% (v/v) glycerol 5% (v/v) glycerol 
Crystal size: < 0.03 mm 0.05~. 1mm 0.2.0.2.0.12 mm 3 
Temperature: 20°C 20°C 20°C 
[Protein]: 8 10 mg/ml 3 mg/ml 3 mg/ml 
Growth time: 5 days 3-4 days 1 week 
All specified values are for the conditions in the droplet after equilibration, aThe conditions for spontanous nucleation were determined with partly 
trypsinized EF-Ts. ~Percentage (v/v) in the reservoir of a saturated (NH4)2SO4 solution. 
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Table 4 
Statistics of a single 20 ° dataset as output from PROCOR 
53 
Resolution (A.) < l/sigl> < I/sigI> Rsy m (%) Rsy m (%) Completeness 
h + k even" h + k odd a P2 C2 (%) 
~6.33 20.22 4.76 8.4 4.4 17.9 
6.33-4.47 11.25 4.69 13.0 8.0 18.7 
4.47-3.65 5.50 4.30 24.2 18.1 16.4 
Data were collected on one crystal during a period of 17 h. The same data were integrated by MADNES in both spacegroup P2 and C2. a< Ilsigl> 
was calculated for data integrated inspacegroup P2. 
asymmetric unit in spacegroup P2 gives a theoretical density of 
1.195 using the model of Westbrook [38] while 7 or 9 monomers 
would result in theoretical densities of 1.171 and 1.220, respec- 
tively. Furthermore an odd number of monomers per asymmet- 
ric unit would be inconsistent with the pseudo-C2 symmetry of 
the primitive spacegroup. With 8 monomers per asymmetric 
unit in spacegroup P2 the Vm = 2.21 /~3/Da which is well within 
the values usually observed [42]. 
4. Discussion 
Expression in the pGEX system proved to be a very efficient 
way of obtaining large amounts of intact EF-Ts. Since the 
purification isessentially a one-step rocedure, the time needed 
is also reduced ramatically thereby minimizing loss of catalytic 
activity during purification. EF-Ts produced in this way was 
shown to be in a catalytically active conformation. EF-Tu has 
previously been expressed in the same system with good results 
[30] and it might therefore be generally applicable for purifica- 
tion of functionally active procaryotic proteins. 
A very rapid trypsin digestion of EF-Ts leading to the pro- 
duction of the C-terminal fragment indicates that the cleavage 
site is located in a highly accessible region of the protein. The 
effect of glycerol on the specificity of the reaction indicates that 
glycerol either protects the region containing the additional 
cleavage site(s) or stabilizes the protein in a conformation 
where this region is inaccessible. A stabilization ofone particu- 
lar conformation is supported by the positive ffect of glycerol 
on crystallization. The decrease of speed of the reaction upon 
addition of glycerol can be explained simply by the increased 
viscosity of the solution. 
Determination f the amino acid composition of the purified 
fragment revealed that the remaining N-terminal fragment of 
5.3 kDa dissociates from the C-terminal fragment after trypsin 
digestion. This indicates that the N-terminal fragment consti- 
tutes a structurally independent domain with a loose associa- 
tion with the rest of the molecule. 
The activity of the C-terminal fragment was estimated to be 
0.15% of the activity of intact EF-Ts and it is therefore con- 
cluded that the N-terminal part of EF-Ts is essential for the 
nucleotide xchange activity. Since the C-terminal fragment is 
able to crystallize the possibility that the decrease in catalytic 
activity is a result of destabilization leading to random rear- 
rangements or denaturation f the fragment is ruled out. The 
very low activity of the isolated C-terminal fragment might 
suggest that the N-terminal part of the protein binds to EF-Tu 
during the exchange reaction. Two studies report that EF-Ts 
from both Thermus therrnophilus [17] and E. coli [43] is pro- 
tected against ryptic cleavage when bound to EF-Tu, indicat- 
ing that lysine-51 and lysine-52 of E. coli EF-Ts are protected 
by this interaction. This makes it likely that the two lysines and 
possibly the N-terminal fragment are located close to the site 
of interaction with EF-Tu, thereby supporting the suggestion 
that the N-terminal fragment is involved in EF-Tu binding. 
Most likely the C-terminal part of EF-Ts also binds to EF-Tu 
since previous tudies (see Introduction) have shown that EF- 
Ts binds to all three domains of EF-Tu. 
Preliminary investigations of the crystals indicate that collec- 
tion of data to a resolution of at least 3.6 A is possible using 
conventional sources. The above mentioned high R-factors of 
the small datasets is most likely a consequence of the X-ray 
induced C2 symmetry of the crystal attice. Crystal decay as 
well as spacegroup transformation in the crystals can probably 
be eliminated by collecting data at cryogenic temperature. 
Crystallization and resolution limit of the data can possibly be 
improved by cloning one of the two C-terminal fragments, 
thereby increasing the homogeneity of the protein. 
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